Feature Papers in Catalysis for Pharmaceuticals
A special issue of Catalysts (ISSN 2073-4344). This special issue belongs to the section "Catalysis for Pharmaceuticals".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 165
Special Issue Editors
Interests: enzymatic synthesis of drugs and bioactive compounds; sustainable processes; biocatalyst upgrading; pharmaceutical industry; organic chemistry; pharmaceutical chemistry
Special Issues, Collections and Topics in MDPI journals
Interests: chemoenzymatic synthesis; medicinal chemistry; biocatalysis; protein engineering
Special Issues, Collections and Topics in MDPI journals
Interests: biocatalysis; nucleoside analogues; bioinformatics; protein structure; enzyme immobilization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Catalysis is crucial in the pharmaceutical industry, enabling various therapeutic compounds' efficient and sustainable production. Its significance lies in enhancing chemical processes' efficiency, selectivity, and environmental compatibility. Catalysts lower the activation energy required for reactions, allowing pharmaceutical compounds to be produced more quickly and cost-effectively under milder conditions. This efficiency is vital in pharmaceutical manufacturing, where speed and cost are critical. Catalysis also ensures high selectivity, forming the desired product over undesired by-products, essential for producing pure pharmaceuticals. This high selectivity reduces the need for extensive purification and minimizes waste, promoting more sustainable practices. Environmentally, catalysis allows reactions to proceed with better resource utilization, reducing the pharmaceutical industry's overall environmental footprint. Green catalysts, such as biocatalysts and recyclable heterogeneous catalysts, further enhance sustainability by reducing the need for hazardous reagents. Furthermore, catalysis is key in developing innovative pharmaceuticals, enabling the synthesis of complex molecules, including enantioselective catalysis for producing chiral drugs with specific biological activities.
This Special Issue aims to explore emerging trends in pharmaceutical catalysis, encompassing homogeneous and heterogeneous processes, as well as photo--, electro-, and enzymatic catalysis for generating bioactive compounds. We aspire for this Special Issue to be a valuable resource for researchers, engineers, and industry professionals in the field of catalysis, as well as for students and academics seeking a deeper understanding of this crucial area of science and technology. Both research and review articles are welcome.
Prof. Dr. Andres Alcantara
Dr. Teodora Bavaro
Dr. Jesús Fernandez Lucas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Catalysts is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- catalysis
- pharmaceuticals
- bioactive compounds
- selectivity
- green chemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
